相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hydrogen Peroxide Sensing and Signaling by Protein Kinases in the Cardiovascular System
Joseph R. Burgoyne et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling
Sang-Heng Kok et al.
ARTHRITIS AND RHEUMATISM (2013)
HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome
Nerea Hermida et al.
CARDIOVASCULAR RESEARCH (2013)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting
Emiliano Angeloni et al.
EUROPEAN HEART JOURNAL (2013)
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Vitamin B or l-arginine supplementation in hyperhomocysteinaemia: think twice!
Jean-Luc Balligand
CARDIOVASCULAR RESEARCH (2012)
Gene Silencing of the Mitochondrial Adaptor p66Shc Suppresses Vascular Hyperglycemic Memory in Diabetes
Francesco Paneni et al.
CIRCULATION RESEARCH (2012)
Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase
Hai-Xiang Sun et al.
HYPERTENSION (2012)
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Eduard Hergenreider et al.
NATURE CELL BIOLOGY (2012)
Differential regulation of metabolism by nitric oxide and S-nitrosothiols in endothelial cells
Anne R. Diers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Moderate Caveolin-1 Downregulation Prevents NADPH Oxidase-Dependent Endothelial Nitric Oxide Synthase Uncoupling by Angiotensin II in Endothelial Cells
Irina Lobysheva et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation Implications for the Antiarrhythmic Effect of Statins
Svetlana N. Reilly et al.
CIRCULATION (2011)
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
Charalambos Antoniades et al.
CIRCULATION (2011)
Synergistic Effect of Combined HMG-CoA Reductase Inhibitor and Angiotensin-II Receptor Blocker Therapy in Patients With Chronic Heart Failure - The HF-COSTAR Trial
Yasuhiro Maejima et al.
CIRCULATION JOURNAL (2011)
Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes
Arash Haghikia et al.
EUROPEAN HEART JOURNAL (2011)
Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading
Chii Yamamoto et al.
HYPERTENSION RESEARCH (2011)
Effects of Lipid-Lowering Therapy with Rosuvastatin on Kidney Function and Oxidative Stress in Patients with Diabetic Nephropathy
Masanori Abe et al.
Journal of Atherosclerosis and Thrombosis (2011)
Statin Therapy for the Prevention of Atrial Fibrillation Trial (SToP AF trial)
Smita Negi et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2011)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Comparison of Atorvastatin 80 mg/day Versus Simvastatin 20 to 40 mg/day on Frequency of Cardiovascular Events Late (Five Years) After Acute Myocardial Infarction (from the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trial)
Terje R. Pedersen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)
John C. LaRosa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability
Marika Massaro et al.
CARDIOVASCULAR RESEARCH (2010)
Oxidative Stress and Vascular Function: Implications for Pharmacologic Treatments
Antje R. Weseler et al.
CURRENT HYPERTENSION REPORTS (2010)
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases
Ming Dong et al.
DRUG DISCOVERY TODAY (2010)
Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction
Dulcenombre Gomez-Garre et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Efflux and uptake transporters as determinants of statin response
Alice C. Rodrigues
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Hypoxic Repression of Endothelial Nitric-oxide Synthase Transcription Is Coupled with Eviction of Promoter Histones
Jason E. Fish et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Promoter Polymorphism of the Endothelial Nitric Oxide Synthase Gene is Associated With Reduced mRNA and Protein Expression in Failing Human Myocardium
Amit A. Doshi et al.
JOURNAL OF CARDIAC FAILURE (2010)
S-glutathionylation uncouples eNOS and regulates its cellular and vascular function
Chun-An Chen et al.
NATURE (2010)
Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
Michael J. Lipinski et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Role of Nox4 and Nox2 in Hyperoxia-Induced Reactive Oxygen Species Generation and Migration of Human Lung Endothelial Cells
Srikanth Pendyala et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation
Sandra B. Haudek et al.
CARDIOVASCULAR RESEARCH (2009)
Evidence for Statin Pleiotropy in Humans Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation
Ping-Yen Liu et al.
CIRCULATION (2009)
Plasma Tetrahydrobiopterin/Dihydrobiopterin Ratio - A Possible Marker of Endothelial Dysfunction
Masafumi Takeda et al.
CIRCULATION JOURNAL (2009)
Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Beate Fisslthaler et al.
CIRCULATION RESEARCH (2009)
AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633
Zhen Chen et al.
CIRCULATION RESEARCH (2009)
Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins
Arnold von Eckardstein et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
'Cellular dysfunction in inflammatory-related vascular disorders' Review Series The inflammatory process: a new dimension of a 19th century old story
Maya Simionescu
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
John G. F. Cleland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Narender Singh et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction
Thomas Muenzel et al.
ANNALS OF MEDICINE (2008)
Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis
Fanny Desjardins et al.
CARDIOVASCULAR RESEARCH (2008)
Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
Oliver Adam et al.
CIRCULATION (2008)
The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels
Akiko Imamura et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription
Wei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
Assam El-Osta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Pleiotropic effects of atorvastatin in heart failure: Role in oxidative stress, inflammation, endothelial function, and exercise capacity
Pablo F. Castro et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma volume - Observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study
Seung Hyuk Choi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Observational Studies of Statins in Heart Failure with Preserved Systolic Function
Hidekatsu Fukuta et al.
Heart Failure Clinics (2008)
Rosuvastatin increases vascular endothelial PPAR gamma expression and corrects blood pressure variability in obese dyslipidaemic mice
Fanny Desjardins et al.
EUROPEAN HEART JOURNAL (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction
Tomasz J. Guzik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1
Melissa Cudmore et al.
CIRCULATION (2007)
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention - Results of the ARMYDA-ACS randomized trial
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Implications of early structural-functional changes in the endothelium for vascular disease
Maya Simionescu
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD
Shane A. Phillips et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Statins activate AMP-activated protein kinase in vitro and in vivo
Wei Sun et al.
CIRCULATION (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace
U Förstermann et al.
CIRCULATION (2006)
Free radicals, metals and antioxidants in oxidative stress-induced cancer
M Valko et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
AK Vyas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin
T Honjo et al.
JOURNAL OF VASCULAR RESEARCH (2006)
Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats
IF Schwartz et al.
KIDNEY INTERNATIONAL (2006)
Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium
JE Fish et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Regulation of endothelial nitric oxide synthase by small RNA
MX Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83
D Fulton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection
Y Rikitake et al.
STROKE (2005)
Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction
C Antoniades et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size
M Yamakuchi et al.
CIRCULATION RESEARCH (2005)
Simvastatin versus ezetimibe -: Pleiotropic and lipid-lowering effects on endothelial function in humans
U Landmesser et al.
CIRCULATION (2005)
Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease
SE Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis
MS Chen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth
CD Searles et al.
CIRCULATION RESEARCH (2004)
Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway
P Vallance et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298→Asp and T-786→C polymorphisms
U Paradossi et al.
STROKE (2004)
Endothelial function - A critical determinant in atherosclerosis?
U Landmesser et al.
CIRCULATION (2004)
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase
U Landmesser et al.
CIRCULATION (2004)
Long-term inhibition of rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice
T Hattori et al.
CIRCULATION (2004)
Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase
RH Böger et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II:: Modulated by G proteins, kinases, and myosin phosphatase
AP Somlyo et al.
PHYSIOLOGICAL REVIEWS (2003)
Oxidized phospholipids as modulators of inflammation in atherosclerosis
N Leitinger
CURRENT OPINION IN LIPIDOLOGY (2003)
Oxygen free radical release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment
C Maack et al.
CIRCULATION (2003)
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice - Evidence for antiinflammatory effects of rosuvastatin
R Kleemann et al.
CIRCULATION (2003)
Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy
K Node et al.
CIRCULATION (2003)
High-density lipoprotein increases the abundance of eNOS protein in human vascular endothelial cells by increasing its half-life
ME Rämet et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo
M Pelat et al.
CIRCULATION (2003)
Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome
LD Monti et al.
DIABETES (2003)
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
U Landmesser et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients
GP Rossi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
ADMA and oxidative stress
K Sydow et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin
H Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis
L Rössig et al.
CIRCULATION RESEARCH (2002)
Association of-786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance
K Ohtoshi et al.
DIABETOLOGIA (2002)
Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation
C Indolfi et al.
CIRCULATION (2002)
Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin et al.
CIRCULATION (2002)
Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice
C Vecchione et al.
CIRCULATION RESEARCH (2002)
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
M Takemoto et al.
CIRCULATION (2002)
HMG-CoA reductase inhibitors improve heart rate variability in patients with a previous myocardial infarction
S Riahi et al.
PHARMACOLOGICAL RESEARCH (2002)
被撤回的出版物: Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells (Retracted article. See vol. 92, pg. 180, 2011)
Y Hattori et al.
CARDIOVASCULAR RESEARCH (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Withdrawal of statins increases event rates in patients with acute coronary syndromes
C Heeschen et al.
CIRCULATION (2002)
Opinion - Does nitric oxide modulate mitochondrial energy generation and apoptosis?
S Moncada et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
U Laufs et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins - An idea whose time for testing is coming, Part I
PK Shah et al.
CIRCULATION (2001)
Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants
JE Tanus-Santos et al.
PHARMACOGENETICS (2001)
Nitrosylation: The prototypic redox-based signaling mechanism
JS Stamler et al.
CELL (2001)
Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease
AN Pehlivanidis et al.
ATHEROSCLEROSIS (2001)
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase
H Duplain et al.
CIRCULATION (2001)
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
IS Yuhanna et al.
NATURE MEDICINE (2001)
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species
S Wassmann et al.
HYPERTENSION (2001)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid
TJ Stalker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells:: Involvement of angiotensin AT1 receptor expression and Rac1 GTPase
S Wassmann et al.
MOLECULAR PHARMACOLOGY (2001)
Cellular regulation of endothelial nitric oxide synthase
R Govers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2001)
LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases
RH Böger et al.
CIRCULATION RESEARCH (2000)
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
U Laufs et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells
DY Li et al.
CIRCULATION (2000)
Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia
C Borghi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production - Key role of L-arginine availability
L Vergnani et al.
CIRCULATION (2000)
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi et al.
NATURE MEDICINE (2000)
Effects of Pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension
SF Su et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury
C Indolfi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
